Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS (Details Narrative)

v3.22.2
DERIVATIVE FINANCIAL INSTRUMENTS (Details Narrative)
Sep. 30, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 15, 2020
$ / shares
shares
Oct. 30, 2020
USD ($)
$ / shares
shares
Feb. 28, 2020
$ / shares
shares
Jan. 06, 2020
USD ($)
$ / shares
shares
Jan. 02, 2020
$ / shares
shares
May 18, 2018
USD ($)
$ / shares
shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants to acquire of common stock | shares     1,650,000          
Warrant exercise price | $ / shares     $ 0.04          
Derivative liability | $ $ 23,609 $ 183,798            
Amended and Restated Loan Agreement [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants to acquire of common stock | shares               320,000
Warrant exercise price | $ / shares               $ 0.10
Derivative liability | $               $ 30,012
Acquisition Note [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants to acquire of common stock | shares           5,000,000    
Warrant exercise price | $ / shares           $ 0.10    
Derivative liability | $           $ 144,259    
Loan Agreement [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants to acquire of common stock | shares       5,000,000 200,000   5,000,000  
Warrant exercise price | (per share)       $ 0.10 $ 0.10   $ 0.10  
Derivative liability | $       $ 95,352